Stanford to test antiviral pills as long COVID treatment
By
Alicia Lasek
Nov 28, 2022
Investigators plan to test whether the antiviral drug Paxlovid will relieve symptoms of the syndrome known as long COVID, also called post-acute sequelae of COVID-19.
NIH: ‘Good’ cholesterol may not universally predict heart disease risk
By
Alicia Lasek
Nov 28, 2022
In a study of 23,000 people, high HDL cholesterol levels were not associated with reduced cardiovascular disease risk, and low levels predicted increased heart disease in white but not Black adults.
Clinical briefs for Monday, Nov. 28
By
Alicia Lasek
Nov 28, 2022
FDA receives over 90K foam-breakdown reports tied to Philips Respironics devices … Vitamin D does not ease muscle aches tied to statin use: study … AMDA, AMA urge clinicians to strongly promote vaccination...
New CMS guidance nudges nursing homes to offer COVID shots, timely treatments
By
Alicia Lasek
Nov 23, 2022
The agency reminds nursing facilities of the requirement to actively offer updated COVID vaccines and urges them to provide approved treatments early to keep mild symptoms from escalating.
HHS report: Time for clinicians to get up to speed on long COVID
By
Alicia Lasek
Nov 23, 2022
Clinicians will play a key role in educating patients about long COVID and its complications, but first they must get up to speed on the multisystem syndrome, the report recommends.
Clinical briefs for Wednesday, Nov. 23
By
Alicia Lasek
Nov 23, 2022
Groups ask CMS to look into ‘disturbing’ hospice growth in three states … 42 new Alzheimer’s genes discovered in large international study … High blood pressure linked to neurotic personality...
Seniors hit hardest as flu rate shoots up in 30 states
By
Alicia Lasek
Nov 22, 2022
Flu activity has jumped across the United States ahead of Thanksgiving, with seniors continuing to have the highest hospitalization rates, according to the latest update from the CDC.
Certain female carriers of Alzheimer’s gene have faster decline than males: study
By
Alicia Lasek
Nov 22, 2022
Women who carry the APOE e4 gene and develop early-onset Alzheimer’s disease may have quicker cognitive decline than men with these attributes, a new study has found.
Antimicrobial stewardship program appears to boost levofloxacin’s powers in study
By
Alicia Lasek
Nov 22, 2022
A pharmacist-led program reduced the use of fluoroquinolone antibiotics by 74% over a five-year period, and appears to have subsequently increased the ability of one of these drugs to fight common bacterial...
Clinical briefs for Tuesday, Nov. 22
By
Alicia Lasek
Nov 22, 2022
FDA: Philips recalls some previously replaced Trilogy ventilators … Anti-hyperglycemic drugs raise risk of MS in patients with diabetes … NIH awards $12M for developing antivirals against viruses...